Phase Genomics

Private

Seattle, WashingtonHealthcare & Life Scienceshttps://phasegenomics.com/

Last Round

Grant

Mar 4, 2024

Total Funding Raised

$21.1M

Company Overview

Phase Genomics is a biotechnology company that develops and sells proximity ligation kits, scientific services, and computational analyses for genomic research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine, Healthcare Analytics

Business Model

B2G

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts, Subscription SaaS

AI Layer

Application

Keywords

Hi-Cchromosome-scale assemblymetagenome deconvolutionHi-C kitsgenome assemblyproximity ligationmetagenomicsmetagenome-assembled genomesMAGsgenome scaffoldingstructural variation analysismicrobiome analysisbioinformatics softwareculture-free metagenomicsplasmid-host linkagecytogeneticssynthetic long-read sequencingplant genomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phase Genomics Comparables

Compare Phase Genomics with similar companies based on industry and business-model similarity.

Phase Genomics comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Phase Genomics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Mar 4, 2024
Grant	Aug 7, 2023
Grant	Jun 9, 2022
Grant	Sep 30, 2020
Grant	Jan 8, 2020
Grant	Feb 25, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Ivan Liachko 🇺🇦

Co-founder & CEO

Founding Team

Phase Genomics Investors

Notable investors and investment history

Phase Genomics investors
Investor	Rounds
National Institute of Allergy and Infectious Diseases	Grant
Mount Pleasant Ventures	Series A
Pack Ventures	Series A
Bill & Melinda Gates Foundation	Grant
Washington Research Foundation Capital	Seed
Congruent Ventures	Seed
Andy Hill Cancer Research Endowment Fund	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 23, 2026
Monthly visitors grew 60% MoM, from 1.9K to 3K.
May 1, 2025
Monthly visitors increased 32% MoM, reaching 3.7K.

View all signals

Phase Genomics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Phase Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Phase Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington

Employee Range14

Year Founded2015

Last FundingMar 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.